Hi guys, Welcome to the Advanced Video Search Engine, and you are watching Weinberg Describes the Available Options for Patients With GIST. That video is uploaded by Targeted Oncology at 2019-12-09T09:52:53-08:00. We are promoting this video only for entertainment and educational purpose only. So, I hope you like & enjoy it. [xOOy5aKrtlk]
| Name | Weinberg Describes the Available Options for Patients With GIST |
| Video Uploader | Video From Targeted Oncology |
| Upload Date | This Video Uploaded At 09-12-2019 17:52:53 |
| Video Discription | Benjamin Weinberg, MD, assistant professor of medicine, and attending physician, Georgetown University Hospital, Medstar Health, discusses the overall prognosis of patients with gastrointestinal stromal tumor (GIST). GIST has an interesting growth pattern. It develops from the stromal tissue, which allows GIST to present anywhere along the gastrointestinal tract. In most cases, if the tumor is surgically removed, outcomes are good. Then, oncologists have to decide if it is necessary to administer therapy after surgery, and which form of therapy is optimal. Weinberg notes that the typical drug used for the treatment of a patient after surgical resection is imatinib (Gleevac), which is given for 1 to 3 years and is followed by a curative surgical resection if the patient is high-risk. In patients with metastatic GIST, physicians also use imatinib, but they also profile patients beforehand to ensure that the patient can respond to the drug. There are other drugs, which are similar to imatinib and can target other poly kinases in patients who are refractory to imatinib. There is a group of patients with mutations that also resist imatinib, and physicians use other drugs for those patients. Overall, Weinberg says there is a variety of targeted oral agents that are effective for the treatment of GIST, even in the metastatic setting. Visit www.TargetedOnc.com for more content related to GIST or other cancers. xOOy5aKrtlk |
| Category | Film & Animation |
| Tags | gastrintestinal stromal tumors | GIST | Benjamin Weinberg MD | Georgetown University Hospital |
